Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
CVS HEALTH Corp
Last earnings +7.6% on 2026-05-06
Revenue grew 7.8% YoY; but thin net margin (0.4%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
CVS HEALTH Corp shows $402B in FY2025 revenue (+7.8% YoY), a 0.4% net margin, and 2.4% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000064803, latest 10-Q filed 2026-05-06) · EODHD · rules-based read · as of 6/17/2026, 6:09:52 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $292B | $322B | $358B | $373B | $402B |
| Gross profit | — | — | — | — | — |
| Operating income | $13.3B | $7.95B | $13.7B | $8.52B | $4.66B |
| Net income | $8.00B | $4.31B | $8.34B | $4.61B | $1.77B |
| Diluted EPS | $6.02 | $3.26 | $6.47 | $3.66 | $1.39 |
| Net margin | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 7 sales
| 2026-05-31 | Newman Brian EVP, Chief Financial Officer | Tax | 2.48K @ $90.98 | $225K |
| 2026-05-31 | Compton-Phillips Amy EVP, Chief Medical Officer | Tax | 7.62K @ $90.98 | $693K |
| 2026-05-21 | AGUIRRE FERNANDO Director | Disposed (D) | 1.56K @ $93.50 | $146K |
| 2026-05-21 | ROBBINS LARRY Director | Sell | 370K @ $93.45 | $34.6M |
| 2026-05-20 | AGUIRRE FERNANDO Director | Disposed (D) | 30.4K @ $93.78 | $2.85M |
| 2026-05-20 | ROBBINS LARRY Director | Sell | 798K @ $93.48 | $74.6M |
| 2026-05-20 | ROBBINS LARRY Director | Sell | 153K @ $94.81 | $14.5M |
| 2026-05-20 | ROBBINS LARRY Director | Sell | 66.9K @ $95.67 | $6.40M |
| 2026-05-20 | ROBBINS LARRY Director | Sell | 800.00 @ $96.28 | $77.0K |
| 2026-05-19 | ROBBINS LARRY Director | Sell | 1.98M @ $94.45 | $187M |
| 2026-05-19 | ROBBINS LARRY Director | Sell | 151.00 @ $95.18 | $14.4K |
| 2026-05-14 | AGUIRRE FERNANDO Director | Award | 1.56K @ $97.15 | $152K |